4.7 Article

Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjogren's Syndrome?

期刊

JOURNAL OF CLINICAL MEDICINE
卷 11, 期 18, 页码 -

出版社

MDPI
DOI: 10.3390/jcm11185405

关键词

primary Sjogren syndrome; interferon gamma; cytokines

资金

  1. Medical University of Wroclaw, Poland [SUB.A270.21.032]

向作者/读者索取更多资源

Primary Sjogren syndrome (pSS) is a complex multifactorial disease, involving various cytokines including interferon. This study aimed to quantify specific cytokines involved in the pathomechanism of pSS and determine their clinical correlation. Results showed that IFN gamma was the most frequently detected cytokine, and was present along with other specific cytokines in most patients. However, no clinical correlation was observed among the three most common cytokines, IL6, IFN gamma, and TNF alpha. These preliminary research findings suggest the possibility of exploring new treatments for pSS.
Background: The pathomechanism of primary Sjogren syndrome (pSS) is multifactorial. Many cytokines take part in this process, including interferon. The study aimed to quantify certain cytokines involved in the pathomechanism of primary Sjogren syndrome (IL2, IL5, IL6, IL10, IL13, TNF alpha, IFN gamma) and determine their common clinical correlation. On this basis, we discuss the potential use of anti-cytokine drugs in pSS therapy. Methods: The study group consisted of adult patients with a confirmed diagnosis of pSS. Results: The most frequently detected cytokines were IFN gamma (82% of patients), TNF alpha (70%), IL6 (50%), and IL2 (42.5%). In all patients, except for one patient, IFN gamma was found in the presence of other specific cytokines. There was no difference in clinical symptoms, age, and laboratory test results between the group of patients with IL-6 + TNF alpha + IFN gamma positive cytokine, and the group of patients in whom they were not detected. There was no correlation between the presence of IL5, IL13, IL2, IL6, IL10, TNF alpha and musculoskeletal symptoms, skin lesions, glandular domains, pulmonary neurological, lymphadenopathy, biological and hematological domains in ESSDAI (p > 0.05). Conclusions: IFN gamma most likely plays a central role in the pathomechanism of the disease. We have not noticed a clinical correlation between the three most common cytokines (IL6, IFN gamma and TNF alpha), preliminary research results open up the possibility of searching for new treatments for pSS. The lower percentage of patients with detectable levels of TNF alpha and IL6 may explain the ineffectiveness of drugs targeting cytokines in clinical trials to date.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据